co-vamloset 10mg+160mg+12,5mg tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+160mg+12,5mg
co-vamloset 10mg+160mg+25mg tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+160mg+25mg
co-vamloset tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 5mg+ 160mg+ 12,5mg
co-vamloset tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+ 160mg+ 12,5mg
co-vamloset tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+ 160mg+ 25mg
co-vamloset tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 5mg+ 160mg+ 12,5mg
co-vamloset tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+ 160mg+ 12,5mg
co-vamloset tablets film-coated
krka-rus llc - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 10mg+ 160mg+ 25mg
copalia hct
novartis europharm limited - amlodipine, valsartan, hydrochlorothiazide - hypertension - angiotensin ii antagonists, combinations, agents acting on the renin-angiotensin system, angiotensin ii antagonists and calcium channel blockers - treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (hct), taken either as three single-component formulations or as a dual-component and a single-component formulation.
dafiro hct
novartis europharm limited - valsartan, hydrochlorothiazide, amlodipine besilate - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (hct), taken either as three single-component formulations or as a dual-component and a single-component formulation.